ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 91 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,929 | -6.7% | 56,615 | +5.7% | 0.00% | – |
| Q2 2023 | $123,142 | -13.4% | 53,540 | +14.0% | 0.00% | – |
| Q1 2023 | $142,273 | +34.6% | 46,955 | +3.5% | 0.00% | – |
| Q4 2022 | $105,686 | +46.8% | 45,359 | +19.5% | 0.00% | – |
| Q3 2022 | $72,000 | -24.2% | 37,965 | +8.3% | 0.00% | – |
| Q2 2022 | $95,000 | +18.8% | 35,040 | +30.3% | 0.00% | – |
| Q1 2022 | $80,000 | -19.2% | 26,898 | +6.0% | 0.00% | – |
| Q4 2021 | $99,000 | -21.4% | 25,385 | -13.0% | 0.00% | – |
| Q3 2021 | $126,000 | +65.8% | 29,180 | +15.9% | 0.00% | – |
| Q2 2021 | $76,000 | -87.2% | 25,186 | -78.5% | 0.00% | – |
| Q4 2017 | $592,000 | -15.4% | 117,321 | +3.9% | 0.00% | – |
| Q3 2017 | $700,000 | +98.3% | 112,927 | +15.1% | 0.00% | – |
| Q2 2017 | $353,000 | +10.0% | 98,090 | -0.7% | 0.00% | – |
| Q1 2017 | $321,000 | – | 98,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
| Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
| FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
| Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
| Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
| Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
| Kepos Capital LP | 155,691 | $316 | 0.06% |
| Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
| Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
| Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |